Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant ...

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...